Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Happy Mohamed

6953 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Management
  • News

Toast Announces Leadership Transition; Aman Narang, Co-Founder And COO, To Become CEO Effective January 1, 2024; Current CEO Chris Comparato To Remain On Board Upon Narang’s Appointment

By Happy Mohamed
September 5, 8:31 AM
Aman Narang, Co-Founder and COO, to become CEO effective January 1, 2024 Current CEO Chris Comparato to remain on Board upon Narang's appointment Toast (NYSE:TOST), the all-in-one digital technology platform built

TOST

Read More
3 minute read
  • News
  • Offerings

Cellectar Biosciences Announces Up To ~$103M Private Placement Financing With Certain Institutional Investors

By Happy Mohamed
September 5, 8:22 AM
Transaction led by existing investor Rosalind with participation from other new and existing healthcare-focused institutional investors   Pivotal topline data in Waldenstrom's macroglobulinemia expected

CLRB

Read More
2 minute read
  • Biotech
  • General
  • News

Avalon GloboCare Announces Notice Of Publication For Key U.S. Patent Filed Jointly With The Massachusetts Institute Of Technology

By Happy Mohamed
September 5, 8:18 AM
 Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced that the United

ALBT

Read More
3 minute read
  • Biotech
  • General
  • News

Elicio Therapeutics To Present Phase 1 Data On Cancer Vaccine Candidate, ELI-002, In Patients With High Relapse Risk Pancreatic And Colorectal Cancers At The AACR Special Conference On Pancreatic Cancer

By Happy Mohamed
September 5, 8:17 AM
Elicio Therapeutics, Inc. (NASDAQ:ELTX, ", Elicio Therapeutics", or ", Elicio", )))), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of

ELTX

Read More
3 minute read
  • Biotech
  • General
  • Global
  • News

Panbela Announces Issuance Of New Patent In Chile For Claims Of A Novel Process For The Production Of Flynpovi

By Happy Mohamed
September 5, 8:16 AM
 Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced an Issue

PBLA

Read More
1 minute read
  • M&A

TFI International Acquires Vedder Transportation Group; No Financial Terms Disclosed

By Happy Mohamed
September 5, 8:14 AM
TFI International Inc. (TSX:TFII), a North American leader in the transportation and logistics industry, today announced the acquisition of Vedder Transportation Group ("Vedder") which specializes in the tank

TFII

Read More
2 minute read
  • Biotech
  • General
  • News

Cadrenal Therapeutics Highlights Additional Need For A New Vitamin K Antagonist Following Updates From The Recent European Society Of Cardiology Congress

By Happy Mohamed
September 5, 8:12 AM
Tecarfarin is the only known Novel Vitamin K Antagonist in Development PONTE VEDRA, Fla., Sept. 5, 2023 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (NASDAQ:CVKD) a biopharmaceutical

CVKD

Read More
2 minute read
  • News

WRC Promoter Expands Live Sports Streaming Service With Harmonic

By Happy Mohamed
September 5, 8:11 AM
Harmonic's VOS360 Media SaaS Offers Reliability and Unparalleled Scalability SAN JOSE, Calif., Sept. 5, 2023 /PRNewswire/ -- Harmonic (NASDAQ:HLIT) today announced that WRC Promoter GmbH, the company

HLIT

Read More
1 minute read
  • Contracts
  • Global
  • News

Vietnam Ministry Of Defense Expands Genasys Contract For Naval Frigates In New $1.9M LRAD-500X-RE And 1000XI Order

By Happy Mohamed
September 5, 8:09 AM
  Genasys Inc. (NASDAQ:GNSS), the global leader in protective communications solutions, today announced a new, $1.9 million LRAD-500X-RE and 1000XI order from the Vietnam Military of Defense

GNSS

Read More
2 minute read
  • Biotech
  • General
  • News

Portage Biotech Announces Collaboration With Merck To Evaluate Two Next-Generation Adenosine Antagonists In Combination With KEYTRUDA In Solid Tumors

By Happy Mohamed
September 5, 8:08 AM
Portage Biotech Inc. (NASDAQ:PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today announced that it has entered into a clinical trial

MRK

Posts pagination

Previous 1 … 42 43 44 … 696 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service